Trademarkia Logo

Canada

C$
F FERRER DESIGN
REGISTERED

on 18 Jun 2018

Last Applicant/ Owned by

FERRER INTERNACIONAL S.A.

Gran Vía de Carlos III94 08028Barcelona

ES

Serial Number

1782051 filed on 12th May 2016

Registration Number

TMA999209 registered on 18th Jun 2018

Registration expiry Date

18th Jun 2033

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

F FERRER DESIGN

Trademark usage description

soaps for personal use; rosehip oils; cosmetics; hair lotions; deodorants for personal use; creams for cosmetic purposes; cosmetic suntan preparations Read More

Vienna Information


26 . 4 . 1

SquaresCarrés

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 8

BlackNoir

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information


Class [003]
Soaps for personal use; rosehip oils; cosmetics; hair lotions; deodorants for personal use; creams for cosmetic purposes; cosmetic suntan preparations; sunscreen preparations, and cosmetic sun-protecting preparations; dermatological creams and lotions (not for medical purposes), namely dermocosmetics, namely skin care preparations


Classification kind code

10

Class [005]
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, coular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations, namely medication for the treatment of colds and flu, cough treatment medications, pharmaceutical preparations for the relief of pain, diarrhea medication, nausea treatment medications fungal medications, acne medications, allergy medications, burn relief medication; pharmaceutical preparations, namely human vaccines; veterinary pharmaceutical preparations, namely for the treatment of infectious diseases in poultry, cattle, pigs, goats, sheep; sanitary preparations for medical purposes, namely disinfectants for hygienic purposes, anti-bacterial pharmaceutical preparations, namely anti-bacterial soap, sanitizing wipes, hand sanitizer, disinfectant soaps, sanitizing sprays; dietetic food and substances adapted for medical use, namely powders, pills, tablets, capsules, gel caps, bars and liquid form for weight loss, weight maintenance and weight gain, increasing energy, assisting digestion, for the treatment of muscle loss, bone loss, muscle deterioration and muscle wasting, for the prevention of bone disease, for the treatment of cardiovascular and respiratory disorders and arthritis, for the treatment of neurological disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's disease, Huntington's disease, cerebral palsy, as well as for anti-aging, anti-wrinkles, skin conditioning and skin firming; dietetic food and substances adapted for veterinary use, namely poultry and livestock food additives for general health, and in the form of vitamins and minerals; food for babies; dietary supplements for humans, namely dietary supplements for general health and well-being, dietary supplements for animals, namely dietary supplements for poultry, cattle, pigs, goats, sheep; nutraceuticals for therapeutic use and for use as a dietary supplement and as a food supplement in the form of powders, pills, tablets, capsules, gel caps, bars and liquid form for weight loss, weight maintenance and weight gain, increasing energy, assisting digestion, for the treatment of muscle loss, bone loss, muscle deterioration and muscle wasting, for the prevention of bone disease, for the treatment of cardiovascular and respiratory disorders and arthritis, for the treatment of neurological disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's disease, Huntington's disease, cerebral palsy, as well as for anti-aging, anti-wrinkles, skin conditioning and skin firming; plaster, dressing material, namely medical, surgical, and wound dressings; disinfectants, namely all purpose disinfectants; disinfectants, namely disinfectants for medical and surgical instruments; preparations for destroying vermin, including lice treatment preparations and insect repellents; fungicides


Classification kind code

10

Class [042]
Medical and pharmaceutical research services; research and development in the field of bacteriology; scientific research for medical purposes; agrochemical research services; chemical research and analysis; consultancy services in the field of pharmaceutical research; technical project studies in the field of pharmaceutical research, bacteriology, medical research, agrochemical research and chemical research; medical laboratory research services


Classification kind code

10

Mark Details


Serial Number

1782051

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 6th Apr 2018
Allowed
Submitted for opposition 42
on 20th Dec 2017
Advertised
Submitted for opposition 26
on 30th Nov 2017
Approved
Submitted for opposition 27
on 13th Oct 2017
Approval Notice Sent
Submitted for opposition 15
on 14th Sept 2017
Correspondence Created
Submitted for opposition 22
on 27th Feb 2017
Search Recorded
Submitted for opposition 20
on 27th Feb 2017
Examiner's First Report
Submitted for opposition 31
on 18th May 2016
Formalized
Submitted for opposition 1
on 13th May 2016
Created
Submitted for opposition 30
on 12th May 2016
Filed